Department of Biotechnology, Yonsei University, Seoul 120-749, Republic of Korea.
Analyst. 2009 Sep;134(9):1896-901. doi: 10.1039/b906788d. Epub 2009 Jul 21.
Severe acute respiratory syndrome coronavirus (SARS-CoV) is the etiological agent of a newly emerged disease SARS. The SARS-CoV nucleocapsid (N) protein is one of the most abundant structural proteins and serves as a diagnostic marker for accurate and sensitive detection of the virus. Using a SELEX (systematic evolution of ligand by exponential enrichment) procedure and recombinant N protein, we selected a high-affinity RNA aptamer capable of binding to N protein with a dissociation constant of 1.65 nM. Electrophoretic mobility shift assays and RNA competition experiments showed that the selected aptamer recognized selectively the C-terminal region of N protein with high specificity. Using a chemiluminescence immunosorbent assay and a nanoarray aptamer chip with the selected aptamer as an antigen-capturing agent, we could sensitively detect N protein at a concentration as low as 2 pg/ml. These aptamer-antibody hybrid immunoassays may be useful for rapid, sensitive detection of SARS-CoV N protein.
严重急性呼吸综合征冠状病毒(SARS-CoV)是一种新发疾病 SARS 的病原体。SARS-CoV 核衣壳(N)蛋白是最丰富的结构蛋白之一,是准确和敏感检测病毒的诊断标志物。我们使用 SELEX(指数富集的配体系统进化)程序和重组 N 蛋白,选择了一种高亲和力的 RNA 适体,能够与 N 蛋白以 1.65 nM 的解离常数结合。电泳迁移率变动分析和 RNA 竞争实验表明,所选适体特异性识别 N 蛋白的 C 末端区域,具有很高的特异性。使用化学发光免疫吸附试验和纳米阵列适体芯片,将所选适体作为抗原捕获剂,我们可以以低至 2 pg/ml 的浓度灵敏地检测 N 蛋白。这些适体-抗体杂交免疫分析方法可能有助于快速、灵敏地检测 SARS-CoV N 蛋白。